Form 6-K QIAGEN N.V. For: Jun 30

August 7, 2026 6:20 AM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

__________________________________

FORM 6-K
 
__________________________________
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the quarterly period ended June 30, 2026
Commission File Number 001-38332
 __________________________________
QIAGEN N.V.
(Translation of registrant’s name into English)
 __________________________________
Hulsterweg 82
5912 PL Venlo
The Netherlands
(Address of principal executive office)
 __________________________________
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F  ý            Form 40-F  o

1

QIAGEN N.V.
Form 6-K

TABLE OF CONTENTS
 
ItemPage
Other Information
Signatures
Exhibit Index

2

OTHER INFORMATION

On June 24, 2026, QIAGEN N.V (NYSE: QGEN; Frankfurt Prime Standard: QIA) held the Annual General Meeting of Shareholders. The related materials are furnished herewith as Exhibit 99.1 to 99.8 and are incorporated by reference herein.
3

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
QIAGEN N.V.
By:/s/ Roland Sackers
Roland Sackers
Chief Financial Officer

Date: August 6, 2026

4

EXHIBIT INDEX
 
Exhibit
No.
  Exhibit
  Notice 2026 AGM QIAGEN N.V.
Proxy Statement 2026
Beneficial Shareholder Attendance Form 2026
Registered Shareholder Attendance Form 2026
Proxy Card for 2026 Annual General Meeting of Shareholders
2026 QIAGEN AGM Voting Results
2025 IFRS Annual Report
2025 Annual Report

5

ATTACHMENTS / EXHIBITS

EX-99.1

EX-99.2

EX-99.3

EX-99.4

EX-99.5

EX-99.6

EX-99.7

EX-99.8



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings